Oleg Nodelman, Director at Kindred Biosciences, Inc. (KIN), bought 85,244 shares at $10.49 ($895K) on 2014-08-25, disclosed to the SEC on 2014-08-27.
Open-market purchase of $895k KIN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.49 | 22,967 | $241K | 26.9% |
| 2 | $10.49 | 27,933 | $293K | 32.7% |
| 3 | $10.51 | 15,497 | $163K | 18.2% |
| 4 | $10.51 | 18,847 | $198K | 22.1% |
| Total | $10.50 avg | 85,244 | $895K | 100% |
| Filing → |
| ZYME | BUY | 2025-03-13 | $26.2M | — | Filing → |
| NUVB | BUY | 2023-09-21 | $6.7M | — | Filing → |
| ANAB | BUY | 2021-05-04 | $5.1M | — | Filing → |